Files

Download

Download Poster (229 KB)

Publication Date

10-2020

Disciplines

Medicine and Health Sciences | Oncology

Comments

Presented at the 2020 ENA Virtual Symposium

Early Evidence of Dose-dependent Pharmacodynamic Activity Following Treatment with SY-5609, a Highly Selective and Potent Oral CDK7 Inhibitor, in Patients with Advanced Solid Tumors

Included in

Oncology Commons

Share

COinS